The University of Akron

IdeaExchange@UAkron
Williams Honors College, Honors Research
Projects

The Dr. Gary B. and Pamela S. Williams Honors
College

Spring 2021

Improving the Monitoring of Post-Operative Patient Mobility
Owen T. Lacey
University of Akron, otl1@uakron.edu

Alexandria Magyar-Averin
University of Akron, alm231@uakron.edu

Elena Ewing
University of Akron, ece14@uakron.edu

Samuel Elliott
University of Akron, soe1@uakron.edu

Cameron Lazor
University of Akron, cel52@uakron.edu
Follow this and additional works at: https://ideaexchange.uakron.edu/honors_research_projects
Part of the Biomedical Devices and Instrumentation Commons, and the Systems and Integrative
Engineering Commons

Please take a moment to share how this work helps you through this survey. Your feedback will
be important as we plan further development of our repository.
Recommended Citation
Lacey, Owen T.; Magyar-Averin, Alexandria; Ewing, Elena; Elliott, Samuel; and Lazor, Cameron,
"Improving the Monitoring of Post-Operative Patient Mobility" (2021). Williams Honors College,
Honors Research Projects. 1309.
https://ideaexchange.uakron.edu/honors_research_projects/1309
This Dissertation/Thesis is brought to you for free and open access by The Dr. Gary B. and Pamela
S. Williams Honors College at IdeaExchange@UAkron, the institutional repository of The University
of Akron in Akron, Ohio, USA. It has been accepted for inclusion in Williams Honors College,
Honors Research Projects by an authorized administrator of IdeaExchange@UAkron. For more
information, please contact mjon@uakron.edu, uapress@uakron.edu.

Improving the Monitoring of Post-Operative Patient
Mobility
Samuel Elliot
Biomedical Engineering
Department
The University of Akron
Akron, USA
soe1@uakron.edu

Elena Ewing
Biomedical Engineering
Department
The University of Akron
Akron, USA
ece14@uakron.edu

Owen Lacey
Biomedical Engineering
Department
The University of Akron
Akron, USA
otl1@uakron.edu

Cameron Lazor
Biomedical Engineering
Department
The University of Akron
Akron, USA
cel52@uakron.edu

Alexandria Magyar Averin
Biomedical Engineering
Department
The University of Akron
Akron, USA
alm231@uakron.edu

I. INTRODUCTION
Post-operative care is vital in a patient’s surgical
recovery. Semple et. al claimed that “The first 30 days
following surgery have been identified as a major focus area in
health care” [1]. Monitoring patients’ mobility during this time
is vital in ensuring their health and wellbeing following surgery.
Physical activity is not just important for physical healing
through ensuring blood circulation, but for mental healing as
well. In an interview with Liz Dewitte, an organ transplant
procurement coordinator, and Andrea Zantopulos, a medical
laboratory scientist, post-operative delirium was discussed as a
reason for mental healing [2]. Dewitte and Zantopulos
explained that delirium is a “sudden confusion”, it changes a
patient's mental function. It can cause patients to become sleepy
and inactive, restricting proper blood circulation from a lack of
activity [2]. Several conducted interviews established that
physical activity is essential in ensuring a successful postoperative recovery process.
Currently, a patient’s mobility score is hand-derived
by physical therapists or nurses. Due to time limitations, these
medical professionals cannot account every mobile activity so
the score only reflects a fraction of the patient’s mobile time.
When a score is determined, it becomes stationary until more
time is available to derive another mobility assessment score.
Thus, a system is needed that can continuously monitor a
patient and provide a mobility assessment score in line with
established and validated methods. This allows medical
professionals to simply interpret the output mobility score and
prescribe the necessary amount of movement. In total, these
efforts will ensure all patients are receiving optimal care during
their post-operative recovery.
Research of current marketed solutions revealed two
distinct product types: physical devices and analytical systems.
The most promising products encompass both approaches.
Patented ideas partially addressing this clinical are available,
one of which is a “patient support apparatus with patient
information sensors” [3]. Here, integrated force gauges monitor
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a patient’s weight while positioned in a surgical bed, but it fails
to provide monitoring of movement outside of the surgical bed
environment [3]. Another patent addresses post-operative
patient mobility through a “pressure-based weight monitoring
system, which determines improper walking or running” [4].
This patent provided guidance in its use determining the postoperative activities patients undergo. Many system-based
patents found defined systems with numerous sensor hubs used
to monitor patient location, but these systems could not monitor
their specific activities [5]. Outside of patented
technology, there are numerous commercial devices that can be
utilized in monitoring post-operative mobility. Some can
collect and display numerous data for interpretation, which can
cause confusion due to lack of training and understanding. For
example, the ActiGraph brand of wearable activity and sleep
monitoring devices can output data via Microsoft Excel, but the
data can be subjective to the physician or nurse reviewing it [6].
II. USER NEEDS
The first design stage served in establishing the
project’s clinical need and its user needs, or stakeholder
requirements. To keep track of the project timeline and goals a
Gantt Chart was utilized, as seen in Figure 1. Research into
current marketed solutions and patents occurred to establish a
knowledge base of relevant technologies. The stakeholder
requirements were derived through interviews with ten medical
professionals having differing experiences with post-operative
care. Questions were developed to gather information on their
experience with post-operative complications specific to
movement. They provided consistent confirmation that
movement monitoring and accountability is crucial for the
success of patient recovery. During recovery, information on
the patient regarding their movement can be difficult to track
due to shift changes within the nursing staff, variance in
movement requirements, and a lack of a quantifiable system to
ease discrepancies between patients and healthcare
professionals. Since communication and continuous patient
monitoring is challenging, it is desired by the stakeholders that
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heart rate be among the recorded data. This information aids the
stakeholders in determining if patients are actively completing
their movement requirements.
A post-operative patient’s recovery process is crucial
to their physical and mental wellbeing. One of the biggest
factors in creating a successful recovery plan is clear
communication. The inconsistencies in the interpretation of
movement requirements between different parties makes
communication difficult. This led to a stakeholder requirement
for a simple device to provide accurate and quantitative data for
a reliable adjustment of recovery plans. This simplicity creates
demonstratable patient accountability for recovery plans.
Through this research, the project scope became clearer. This
project is dedicated to engineering a medical device that
monitors and quantifies the mobility of post-operative patients
that is easily understood by medical professionals and patients
alike.
III. DESIGN INPUTS
The clinical need and stakeholder requirements served
as inputs into the design inputs stage. Here the engineering
requirements were derived using quality functional
deployment, or QFD. These engineering requirements guided
the development of the device and an initial route for solutions.
The most important customer requirement to convert was the
quantification of patient movement. This led to the following
engineering requirements: sensor input information, data
availability, heart rate and accelerometer divisions, and
numerical scale output. These engineering requirements serve
in gathering patient information from physical sensors to
determine a representative value of their post-operative
movement.
Three other engineering requirements derived from
the customer requirements included physical sensor inputs,
code runtime, and device runtime. The physical sensor inputs
requirement allowed for proactive thought surrounding a
solution with a small footprint and ideal location for patient use
and comfort. The code and device runtime requirements
provided guidelines for ensuring the solution would function
and respond to inputs sufficiently for diagnostic analysis and
patient treatment. Figure 2 has more information regarding the
coordination of the customer and engineering requirements.
IV. DESIGN PROCESS
Once the design inputs were determined, the initial
design process began. Potential solutions were brainstormed
using a variation of Method 635. Brainstorming was broken
down into three categories: functional device concepts
including data processing and gathering, form factor, and
device output. From here, decision matrices were utilized to
weigh the discussed options. Down select analyses and results
concerning these options can be viewed in Figures 3 and 4.
After team discussions, research and preliminary failure modes
and effects analysis (FMEA) risk assessment for each
technology, the pulse oximeter, accelerometer, external
application, Bluetooth communication, and wrist-based
location were selected for use in the developing solution. In
establishing which components were utilized, the
accelerometer data to gather and utilize for mobility assessment
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scoring was also determined. It was determined that gathering
accelerometer data to convert to a static value of steps would be
the most appropriate for our developed solution. From here,
novel code could be developed to indicate when steps are
completed by a patient. A numerical scale output was selected
for use with this data. The Boston University Activity Measure
for Post-Acute Care (AM-PAC) was selected for use after
deliberation with Dr. Vazquez at the Cleveland Clinic (D.
Vazquez, personal communication, October 21, 2020).
Specifically, the Basic Mobility Domain was selected as it was
most applicable to patient movement in terms of steps. Ensuring
a validated process for scoring is selected allows for a more
seamless integration of our developed solution into a hospital
environment.
V. DESIGN OUTPUTS
In the design output stage, component selection
ensued. A PulseSensor and Arduino Nano 33 BLE Sense were
selected to satisfy the pulse sensor, accelerometer, and
Bluetooth communication requirements defined in the design
process stage. The accelerometer used in the Arduino Nano 33
was part of an onboard LSM9DS1 9-Axis Inertial Measurement
Unit, a device using a combination of accelerometers,
gyroscopes, and magnetometers to determine position changes
from a wide variety of perspectives. For this project, only the
3-axis accelerometer package of the IMU was utilized, as
acceleration data was the most pertinent to the project needs.
Initially Evothings Studio was selected as the external
application platform, but after further deliberation and
experimentation, MATLAB App Designer was chosen. This
application would display input step and heart rate data as well
as an output AM-PAC mobility score, the software flow chart
for which can be found in Figure 5. In coming to these
decisions, decision matrices were utilized, which can be found
in Figures 6 and 7. Notably, these matrices pointed out the
benefits of the Arduino Nano 33 BLE Sense. When compared
to other available Arduino Nanos, this one had the advantage of
an onboard accelerometer and bluetooth module. Since the
team had some unfamiliarity with the Arduino Nano’s
accelerometer, an Adafruit accelerometer was chosen as an
alternative/backup to ensure accelerometer data could be
reliably gathered. These decision matrices pointed out the
advantages and disadvantages of using MATLAB App
Designer over Evothings Studios. Finally, a power source, in
the form of a lithium-ion battery was selected for
implementation in the solution. This battery was specified as
capable of supplying 3.7V for 2000mAh.
An external casing was then designed to house the
chosen electronic components. Another decision matrix was
used to determine various component placement within the
device, seen in Figure 8. Ultimately, the lithium-ion battery was
placed on the bottom of the case, with vertically layered
components above it to provide stability and a passive casing
not interfering with patient activities. The PulseSensor would
be placed outside of the casing with an external plug-in port.
This allowed for easy accessibility to accurate information from
the fingertip. In providing structure to the case, three plastic
boards were designed to support the electronic components.
These boards were spaced vertically with brass spacers, and
when fully assembled, acted as one part. These designs can be
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found in Figures 9 through 13. The two case pieces fit together
vertically and are fastened together with 4 countersunk. Figure
14 outlines the complete device casing assembly, and it
includes the bill of materials of all included components in its
construction.
Finally, a conversion of the AM-PAC Basic Mobility
Domain for use with step and heart rate data could be completed
and coded into MATLAB. First, from the Basic Mobility
Domain, various patient activities were selected. The score
associated with each activity was taken from the chart in Figure
15. Using the bathroom, moving between the bed and chair,
walking within the room/hallway, walking around the hospital
floor, power walking, and light-weight exercise were selected
as the events to monitor. Each of these activities were allocated
a score in accordance with the AM-PAC; this score is derived
from the threshold between whether a patient can complete an
activity with some difficulty or cannot complete it at all. After
team discussion and simulation, each of these activities were
assigned a threshold step and heart rate value. The input data
from the device could then be utilized to see whether a patient
completed an activity. Here, the periodic increase and
stabilization of collected steps can be filtered to determine
when a movement activity has occurred and which AM-PAC
activity was completed.
To determine when a step has been taken, the current
data from each axis of the accelerometer is measured, and the
magnitude of the entire vector is then determined by squaring
each value, summing them, and taking the square root of the
resulting sum. This value is then compared to a threshold value,
and if the value is greater than the threshold, then a step is
considered to have been taken. This threshold value was
experimentally determined to increase the code’s accuracy.
Figure 16 gives a sample of collected x-axis, y-axis, and z-axis
accelerometer data (in g) displayed per sample taken. Here, two
simulated steps are taken; the x-axis represents the
superior/inferior motion of the wrist, the y-axis represents the
medial/lateral motion of the wrist that is relatively minimized
during normal walking gait, and the z-axis represents the
anterior/posterior motion of the wrist. During walking gait, the
periodic swinging of the arms results in sudden decrease,
increase, and stabilization of the x-axis and z-axis acceleration
values. With it being periodic, this data can thus be utilized in
determining when a step occurs according to recorded
accelerometer values.
VI. DESIGN VERIFICATION
Once the design had been developed and finalized, an
analysis of the design to verify its satisfaction of all engineering
requirements ensued. Though a full beta prototype was
unavailable at this stage in the design process, an alpha
prototype with partial functionality provides a benchmark.
Here, two Arduino Unos were utilized: one with a PulseSensor
and one with an Adafruit accelerometer. Both electronic
components had supplemental code libraries ready for use from
the manufacturer. Data were readily available for collection and
could be tested against other industry standard devices. On top
of code collection and accuracy, ensuring the alpha prototype
has mechanisms to store and export data, rapid code runtime,
and sufficient device runtime are essential. The verification
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summary table, found in Figure 17 outlines the verification
tests, target values, and the results.
The results largely verified the developed design’s
ability to meet the engineering requirements. The accuracy of
gathered heart rate data was identical to the Metene fingertip
pulse oximeter, an industry standard, at ±1 beats per minute.
The measured code runtime of the designed beta prototype fell
well below the engineering requirement target of less than 3
minutes. Successful demonstrations occurred showing the code
implemented for storing and exporting data. Calculations were
performed to ensure the designed beta prototype’s battery could
provide continuous operation for at least 36 hours. These were
done by summing the specified mA draw of each component
and multiplying by the desired runtime of 36 hours. Then, this
value was divided by 0.8 to account for battery degradation
over time. After this was determined, a battery requirement of
about 1150mAh was determined with the current battery
selection exceeding this requirement. One area where the
verification testing failed, however, was in the collection of
accelerometer data in the form of steps. When a prescribed 50
steps were taken, an Apple Watch recorded 52 steps while the
Adafruit accelerometer only recorded 22 steps. When analyzing
the Adafruit accelerometer’s supplemental code, a large amount
of calibration time was found that prevented the gathering of
accelerometer information over about half of the working time
of the accelerometer.
VII. MEDICAL DEVICE
The completed beta prototype addressing the initial
clinical need is shown in Figure 18. A video link of the working
design can be found in Figure 19. Problems determined during
verification testing were resolved during this stage in the
implementation of novel code for determining when patients
were taking steps. This differed from the code used in the
original alpha prototype, given manufacturer provided code for
the Adafruit accelerometer caused a surplus of calibration time
that was eliminated during the switch to the Arduino Nano 33
BLE Sense. The completed beta prototype will demonstrate the
ability to accurately record step information from
accelerometer data and be used with heart rate data. These
inputs are then exported via Bluetooth and allow for the
calculation of an AM-PAC score. During this stage, however,
the external application was cut from the scope of the project
due to difficulties learning and sufficiently implementing this
system into the prototype solution. Instead, the output data from
the physical device was recorded via Bluetooth to a Microsoft
Excel file for further analysis and historical record. Ultimately,
the developed solution aids in describing the patient’s mobility
throughout the day for medical professionals.
VIII. VALIDATION TESTING
With a completed prototype solution, validation
testing could begin to address how the solution meets the
stakeholder requirements defined in the user needs stage.
During testing, the completed beta prototype was utilized and
assessed with four validation tests: physical device
interference, device use, input data analysis, and output data
analysis. The input data analysis addresses the accuracy of the
collected steps and heart rate data. Here, the prototype will be
attached to a simulated patient alongside a Metene pulse
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oximeter. The simulated patient will then walk 120 steps during
which step and heart rate data is collected. This was then
repeated with only 60 steps being taken. This data will then be
compared to the prescribed steps and Metene pulse oximeter. If
the collected steps fall within ±5 steps and the heart rate fall
within ±2BPM, each test will receive a pass. The interference
and output data analysis tests follow a similar format; full
validation testing protocols can be found in Figure 20. The
device uses test functions as a demonstration of the device’s
capability to connect to the external application over bluetooth
and successfully transfer data.
The results largely validated the developed design’s
ability to meet the stakeholder requirements and address the
clinical need effectively. The physical beta prototype device did
not significantly inhibit common patient activities including
using a smartphone, opening a door, drinking fluids, etc. The
device was able to connect to Bluetooth reliably and remain
connected as the simulated patient performed mobility-based
activities. The data collected was also consistently output to a
Microsoft Excel file for AM-PAC scoring and historical record.
Similarly to the verification testing, the accuracy of the
collected step and heart rate data was analyzed. Here, the novel
steps code provided an accurate solution to the previously failed
verification test. The heart rate data continued to be exported
within ±2BPM of the Metene pulse oximeter. Finally, the
collected data was used to calculate an AM-PAC mobility
score, and the scores came out accurate when compared to the
expected averages due to multiple mobility activities occurring.
IX. RISK MITIGATION PROCESS
During each gate in the FDA’s medical design
process, risk assessments were performed using FMEA. This
process identified outlying risks, their severity, and methods for
mitigating these risks throughout the design process. Each risk
was allocated a value from 1 to 10, based on group discussions
and literature, for the risk’s severity, occurrence, and detection.
The risks with the highest risk priority number (RPN)
comprised the most pressing potential hazards present in our
device. The FMEA summary can be found in Figures 22 and
23. The risk with the highest RPN concerned the data
processing application crashing, rendering output data
inaccessible for mobility assessment. To mitigate this risk,
MATLAB code was implemented to save input step, input heart
rate, and output AM-PAC scores in an external spreadsheet for
access outside the application environment. This mitigation
also addressed another potential hazard regarding data
overflowing and overwriting previously recorded step, heart
rate, or AM-PAC score data. Another pressing potential hazard
concerned the sufficient powering of all device components.
Here, battery calculations were performed alongside previously
discussed component specifications to ensure a properly sized
battery was selected for use. Here, a 3.7V 2000mAh (milliamphour) battery was selected for use alongside a PowerBoost
Charger capable of converting the 3.7V to 5.0V and charging
the device and a 3.3V Buck Converter capable of converting the
5.0V to 3.3V to ensure compatibility with all device
components and overall device safety. In performing research
and calculations regarding each hazard, mitigations were
created such that each of these risks could be diminished to an
acceptable level for clinical use.
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X. MARKETING AND MANUFACTURING CONSIDERATIONS
The market for this device is hospitals looking to help
patients with post-operative care. The size of the market is quite
large as there are 6,090 hospitals within the United States and
“48 million surgical inpatient procedures” [9] [10]. This gives
a scale of how many patients may need to be monitored postsurgery. At this point in time, an estimated manufacturing cost
would be about $431.04, after doubling the material cost of
$67.35 for labor cost, doubling that total for company overhead
and adding sixty percent for margin. Project expenses and the
wholesale prices can be found in Figure 24. This sell price is
not competitive in terms of the physical device itself. A FitBit
HR sells for around $150 [9]. This makes the physical device
not very competitive with the current technology at this point
from a price standpoint. On the other hand, our device is
offering an app solution with the physical device. The current
marketing of application solutions is turning toward
subscription-based services. Since apps require constant
updates to keep current, a subscription cost could bridge the
profit gap by dropping the initial price.
XI. SUMMARY FEASIBILITY DISCUSSION
This design is a proof of principle for the established
clinical need. The developed solution proves that a physical
activity monitoring system can be created to monitor the
activity of the patient and return a validated patient movement
score to the hospital staff. In this case, it was able to generate
an estimated AM-PAC score based on its Basic Mobility
Domain. The coding of the device could be improved to cover
an increased number of AM-PAC guidelines, giving a more
accurate patient score. Further testing of the established AMPAC software would provide more information in determining
more accurate scores. Overall, this proof of principle prototype
shows that the development of this type of solution is possible.
XII. DISCUSSION, LESSONS LEARNED, AND CONCLUSIONS
Throughout the development of our solution, our team
encountered a few obstacles, notably during the design outputs
and medical device stages of the FDA’s design process. As we
moved into the design outputs stage, the overarching scope of
our selected project and solution came into view. To develop a
proper solution, a good amount of outside learning pertaining
to app development and electronics was required. This resulted
in each team member becoming exclusively assigned to one
task a piece as opposed to sub-teams. On top of each team
member working largely independently, the ongoing COVID19 pandemic hindered plans further. Most of our team members
came down with COVID-19, halting their progress as they
fought and recovered from the novel virus. Learning curves
inhibited other team members from stepping in to assist.
COVID-19 and the exposure of our team members to it
drastically limited the ability for in-person work.
When time became a constraint for our team, we
worked together to ensure all current stage requirements were
met appropriately. Team members were compassionate and
understanding with each other when illness, family emergency,
or other situations arose. Had the true scope of the project been
known prior to the final design process stages, our team would
have worked to develop a smaller scope for our project. To this
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point, focusing our efforts on developing an extremely accurate,
easily implementable electronic device would have better
focused our scope. If more time were allocated to clinical need
research, a clinical need outside the realm of electronics could
have been developed.
XIII. FUTURE WORK
In the development of the solution to the clinical need,
an innovative solution has been created addressing this gap in
the market. However, given more time, resources, and
knowledge, a more refined and standardized solution can be
developed. The current solution presents itself as modular with
larger-sized components. With the electrical knowledge, the
current design’s size can be drastically reduced into a nimbler
package. The background code implemented can be refined to
function more efficiently with more failsafes counteracting
improper use. One of the larger areas for future improvement
lies in the code’s detection of an increasing number of patient
post-operative actions. Currently, the designed device gathers
and compares data against select actions in the AM-PAC’s
Basic Mobility Domain as it pertains to step and heart rate data.
The AM-PAC mobility scoring system incorporates actions
past walking including sitting down, standing up, body shifting,
walking up and down stairs, bending over, etc. With more
movement possibilities, improvements can be made in sensor
inputs, data collection, and AM-PAC score calculation to
encompass a wider range of patient post-op activity.
XIV. INDIVIDUAL ROLES AND RESPONSIBILITIES
Samuel Elliott acted as the design lead throughout the
design process, and his efforts were essential in beta prototype
development. He aided in deriving the design inputs and
outputs from the engineering requirements, as well as
spearheading the design process. He worked in selecting the
most fitting electronic components for use in the developed
solution. Sam completed a vast majority of the device’s
prototyping and troubleshot some communication and coding
issues that arose.
Elena Ewing acted as the product manager throughout
the design process. She oversaw customer and stakeholder
communication and executed interviews to determine the
clinical need. She performed further research into the clinical
need to aid in determining the engineering requirements. Elena
then shifted focus to education and implementation of an
external application solution.
Owen Lacey acted as the team administrator
throughout the development of the medical device. He worked
as a meeting moderator and sparked productive conversation
regarding action items throughout the design process. He
developed engineering requirements via quality functional
deployment (QFD), identified potential risks via failure modes
effects analyses (FMEA), dissected AM-PAC documentation to
derive a method for calculating a mobility score, and developed
code to input, calculate, output, and save various data gathered
from the patient. Finally, he worked in defining, developing,
and executing the verification and validation protocols.
Cameron Lazor acted as the quality lead throughout
the gate-design process. Cameron completed many stakeholder
interviews and researched to aid in establishing the clinical
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need. He oversaw the documentation process alongside
Alexandria, notably in the documentation of the verification
and validation plans and reports. Further, he served as a
consultant during all verification and validation activities.
Alexandria Magyar Averin acted as management of
the project. She was responsible for discussion facilitation and
moderated team dynamics issues throughout the design
process. She focused on the development and the design of the
external case and internal supporting structures in SolidWorks
and provided a source for 3D printing these components.
Furthermore, Alexandria organized the documentation
throughout the team’s Google Drive to meet DHF standards.
XV. PROFESSIONAL AND ETHICAL RESPONSIBILITIES
As biomedical engineers, we are expected to operate
using the highest standards of integrity and honor. That ethical
responsibility requires us to work while keeping public health,
safety, and equity in the highest regard. Professional
responsibilities require this team to conduct themselves
ethically and lawfully to enhance the reputation of this device
and the engineering profession. Throughout the design process
of this device, this team operated abiding by these ethical
responsibilities while maintaining a respectful and professional
outlook.
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APPENDIX A: DEFINITION OF PROJECT GOALS AND TIMELINE

Figure 1: Gantt Chart
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APPENDIX B: QUALITY FUNCTIONAL DEPLOYMENT UTILIZED IN ESTABLISHING ENGINEERING REQUIREMENTS

Figure 2: Stage 1 QFD Engineering Requirements
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APPENDIX C: RATIONALES, DECISION MATRICES, AND SOLIDWORKS DESIGNS UTILIZED IN SOLUTION DEVELOPMENT

Figure 3: Down Select Analysis for Device Location

Figure 4: Down Select Analysis for Data Display
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Figure 5: Software Flow Chart

Figure 6: Software Decision Matrix
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Figure 7: Electronics Decision Matrix

Figure 8: Decision Matrix for Form Factor and Device
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Figure 9: SolidWorks Drawing of Bottom Case Component
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Figure 10: SolidWorks Drawing of Battery Board Case Component
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Figure 11: SolidWorks Drawing of Layer Board 2 Case Component
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Figure 12: SolidWorks Drawing of Layer Board 1 Case Component
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Figure 13: SolidWorks Drawing of Top Case Component
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Figure 14: SolidWorks Exploded Assembly of Device Casing and Electronics
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Figure 15: AM-PAC Basic Mobility Domain
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Figure 16: Sample of Gathered Acceleration Information (X-Axis: Sample; Y-Axis: Acceleration in g)
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APPENDIX D: TABULATED DESIGN VERIFICATION PROCESS AND RESULTS

Figure 17: Verification Summary Table
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APPENDIX E: COMPLETED BETA PROTOTYPE FIGURES AND SUPPLEMENTAL DEMONSTRATION

Figure 18: Completed Beta Prototype Figure
TO BE COMPLETED
Figure 19: Video Link of Functional Beta Prototype

May 2021

21

APPENDIX F: TABULATED DESIGN VALIDATION PROCESS AND RESULTS

Figure 20: Validation Testing Guidelines and Protocols
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Figure 21: Validation Summary Table
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APPENDIX G: SUMMARY OF RISK MITIGATION ACTIVITIES

Figure 22: Design Process FMEA Summary – Risks 1 through 16
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Figure 23: Design Process FMEA Summary – Risks 17 through 31
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APPENDIX H: SUMMARY OF PROJECT EXPENSES AND PRODUCT MARKETING ANALYSIS

Figure 24: Bill of Materials with Wholesale Price for Product Marketing Assessment
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